Lawrence Bloch
Vorstandsvorsitzender bei NeurAxon Pharma, Inc.
Vermögen: 97 $ am 31.01.2024
Aktive Positionen von Lawrence Bloch
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
NeurAxon Pharma, Inc.
 NeurAxon Pharma, Inc. Miscellaneous Commercial ServicesCommercial Services NeurAxon Pharma, Inc. researches and develops nervous system disorder therapies. The company is headquartered in Mississauga, Canada. | Vorstandsvorsitzender | - | - |
| Präsident | - | - |
Karriereverlauf von Lawrence Bloch
Ehemalige bekannte Positionen von Lawrence Bloch
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| INFINITY PHARMACEUTICALS, INC. | Comptroller/Controller/Auditor | 07.04.2013 | 02.05.2016 |
| Finanzdirektor/CFO | 24.07.2012 | 04.01.2017 | |
| Präsident | 04.01.2017 | 31.03.2023 | |
| Unternehmenssekretär | 24.07.2012 | 25.07.2016 | |
| Treasurer | 24.07.2012 | 31.03.2023 | |
NeurAxon, Inc.
 NeurAxon, Inc. Miscellaneous Commercial ServicesCommercial Services NeurAxon, Inc. is engaged in the research and development of growing and unmet needs for chronic pain management. It is focused on developing pain therapeutics targeting neuronal Nitric Oxide Synthase (nNOS) inhibitors. The companyw as founded in 2004 and is headquartered in Mississauga, ON. | Direktor/Vorstandsmitglied | 01.01.2007 | 01.01.2011 |
| Vorstandsvorsitzender | 01.01.2007 | 01.01.2011 | |
| Präsident | 01.01.2007 | 01.01.2011 | |
NitroMed, Inc.
 NitroMed, Inc. Pharmaceuticals: MajorHealth Technology NitroMed, Inc. develops and supplies pharmaceuticals. It offers BiDil, an orally administered medicine for the treatment of heart failure. The firm also develops products for cardiovascular and metabolic diseases. The company was founded in 1987 and is headquartered in Atlanta, GA. | Finanzdirektor/CFO | 01.01.2004 | 01.01.2006 |
Applied Molecular Evolution, Inc.
 Applied Molecular Evolution, Inc. Medical/Nursing ServicesHealth Services Applied Molecular Evolution, Inc. provides healthcare support services. It develops novel human biotherapeutics cytokines, hormones, and enzymes. The company was founded in 1989 by Bill Huse and is headquartered in San Diego, CA. | Finanzdirektor/CFO | 01.01.1999 | - |
Ausbildung von Lawrence Bloch
| Harvard Law School | Graduate Degree |
| Harvard Medical School | Doctorate Degree |
| Harvard Business School | Masters Business Admin |
Statistik
International
| Vereinigte Staaten | 7 |
| Kanada | 3 |
Operativ
| Director of Finance/CFO | 3 |
| President | 3 |
| Chief Executive Officer | 2 |
Sektoral
| Consumer Services | 4 |
| Commercial Services | 3 |
| Health Technology | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| INFINITY PHARMACEUTICALS, INC. | Health Technology |
| Private Unternehmen | 4 |
|---|---|
Applied Molecular Evolution, Inc.
Applied Molecular Evolution, Inc. Medical/Nursing ServicesHealth Services Applied Molecular Evolution, Inc. provides healthcare support services. It develops novel human biotherapeutics cytokines, hormones, and enzymes. The company was founded in 1989 by Bill Huse and is headquartered in San Diego, CA. | Health Services |
NeurAxon, Inc.
NeurAxon, Inc. Miscellaneous Commercial ServicesCommercial Services NeurAxon, Inc. is engaged in the research and development of growing and unmet needs for chronic pain management. It is focused on developing pain therapeutics targeting neuronal Nitric Oxide Synthase (nNOS) inhibitors. The companyw as founded in 2004 and is headquartered in Mississauga, ON. | Commercial Services |
NitroMed, Inc.
NitroMed, Inc. Pharmaceuticals: MajorHealth Technology NitroMed, Inc. develops and supplies pharmaceuticals. It offers BiDil, an orally administered medicine for the treatment of heart failure. The firm also develops products for cardiovascular and metabolic diseases. The company was founded in 1987 and is headquartered in Atlanta, GA. | Health Technology |
NeurAxon Pharma, Inc.
NeurAxon Pharma, Inc. Miscellaneous Commercial ServicesCommercial Services NeurAxon Pharma, Inc. researches and develops nervous system disorder therapies. The company is headquartered in Mississauga, Canada. | Commercial Services |
- Börse
- Insiders
- Lawrence Bloch
- Erfahrung
